Artificial intelligence at Novartis has advantages for both the business and its employees. The Swiss-American company is employing AI to analyze all the data from the tens of thousands of trials it has carried out over the years.
On the basis of those revelations, its algorithms are locating chemicals that might be combined to produce novel medications.
The company merely tests the most promising leads that the A.I. proposes, saving them from having to go through the laborious process of trying with every chemical and every combination. As a result, Novartis is launching new medications in less time and spending less on R&D.
Novartis’ employees have not suffered as a result of utilizing artificial intelligence, and its scientists have not ceded control to the machine.
On the contrary, owing to technology, scientists can now concentrate on tasks that bring more value because they are not required to sift through several documents to find data. The scientists are also refining their grasp of chemical properties and fostering their creativity by building on the A.I.’s data-based recommendations, which is enabling them to create unique molecular combinations more quickly.
Instead of artificial intelligence, the technology may readily be referred to as enhancing intelligence. A common misconception is that organizations use artificial intelligence to create value at the expense of their workforce, but this is largely untrue.
Our research demonstrates that technology has advantages for both businesses and workers. According to the newly released 2022 BCG – MIT SMR A.I. Report, only 7% of employees think that utilizing AI benefits them little or not at all but benefits their company. In fact, up to 64% of workers claim that employing AI at work has benefited them personally.
And even though it’s often believed that AI makes workers feel inferior, only 8% of people reported a decline in job satisfaction as a result of employing the technology.
